Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aelin Therapeutics

Request full access

Develops peptide-based therapeutics that induce targeted protein aggregation to neutralise disease-causing proteins

Leuven, BelgiumFounded 2017Biotech & Life Sciences

About Aelin Therapeutics

Aelin Therapeutics, founded in 2017 as a spin-off from VIB and partner universities KU Leuven, VUB, and UGent, is a privately held Belgian company. The company has secured a 27 million Euro Series A investment from a reputable investor syndicate. Aelin Therapeutics specializes in developing Pept-ins™ technology, a novel class of peptide-based therapeutics designed to target high-value undruggable proteins. These proteins are often involved in diseases such as cancer, where traditional drug modalities have failed. The company leverages its unique mode of action, designability, and intracellular target space to create effective treatments. Pept-ins™ can be tailored to target either a single protein or an entire family of proteins, offering broad applicability. Proofs of concept have demonstrated the technology's potential in functional knockdown of mammalian, bacterial, viral, and fungal protein targets for the treatment of human diseases. Aelin Therapeutics operates in the biotechnology and pharmaceutical markets, primarily serving clients in the healthcare sector. The business model focuses on research and development, with revenue generated through partnerships, licensing agreements, and potential future product sales.

Source: Dealroom company data

At a glance

Status
Closed
Employees
20
Open positions
None listed
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Oncology, Spinout, Biotech and Pharma, Digital Pharma, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2017 $30M $119M FundPlus · Boehringer Ingelheim Venture Fund · PMV · Novartis Venture Fund ↗
SPINOUT✓Other financing Jan 2017 $0 — Ghent University · Flanders Institute for Biotechnology · KU Leuven —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Aelin Therapeutics website traffic

Latest recorded traffic for Aelin Therapeutics is 0 monthly website visits. Aelin Therapeutics's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Aelin Therapeutics in the Leuven ecosystem

Live from Dealroom

The Aelin Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • EQT Life Sciences
  • FundPlus
  • Boehringer Ingelheim Venture Fund
  • PMV
  • Novartis Venture Fund

Other known investors4 additional known investors

  • Flanders Institute for Biotechnology
  • Ghent University
  • KU Leuven
  • Gemma Frisius Fund - GFF
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇧🇪 Belgium · Leuven HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aelin Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aelin Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.